| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 06/04/2008 | CN101193877A Agent for treatment of hematopoietic tumor |
| 06/04/2008 | CN101193867A N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library |
| 06/04/2008 | CN101190913A Novel compound with antiviral activity |
| 06/04/2008 | CN101190912A Antiviral compound and preparation method thereof |
| 06/04/2008 | CN100391944C Indoles useful in the treatment of androgen-receptor related diseases |
| 06/03/2008 | US7381825 Antiinflammatory agents; skin disorders; inflammatory bowel disorders |
| 06/03/2008 | US7381824 Quinoline derivatives |
| 06/03/2008 | US7381749 Sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 06/03/2008 | US7381743 Macrocycles for the treatment of cancer |
| 06/03/2008 | US7381741 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors |
| 06/03/2008 | US7381734 Serine protease inhibitors |
| 06/03/2008 | US7381723 Antiserotonine agents; stroke, brain disorders;trauma; Alzheimer's disease; neurodegenerative disease; schizophrenia; psychological disorders; anxiolytic agents; controlling stresses; eating disorders; sleep disorders; sexual disorders |
| 06/03/2008 | US7381719 To treat obesity and Related Diseases; oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; weight loss while maintaining or minimizing the loss of lean muscle mass; 6-[4-(2-Benzylamino-ethyl)-phenoxy]-nicotinamide |
| 06/03/2008 | US7381687 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides |
| 06/03/2008 | CA2283465C Pesticidal 1-aryl-3-iminopyrazoles |
| 05/29/2008 | WO2008064218A2 Amido anti-viral compounds |
| 05/29/2008 | WO2008063781A2 Chemical compounds as cannabinoid receptor ligands |
| 05/29/2008 | WO2008063625A2 Pyridine compounds and methods of their use |
| 05/29/2008 | WO2008062905A2 Heteromonocyclic compound and use thereof |
| 05/29/2008 | WO2008062878A1 Novel pyrazole derivative, harmful organism control agent, and use of the control agent |
| 05/29/2008 | WO2008062739A1 Pyrazoles and use thereof as drugs |
| 05/29/2008 | WO2008062244A1 Polymorphs of 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one hydrobromide and processes for preparation thereof |
| 05/29/2008 | WO2008062151A1 Process for the purification of meloxicam |
| 05/29/2008 | WO2008062011A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods |
| 05/29/2008 | WO2008045673A3 Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents |
| 05/29/2008 | WO2008045564A3 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | US20080125587 Synthesis of triazole compounds that modulate HSP90 activity |
| 05/29/2008 | US20080125471 Water-Soluble Tetrazolium Salts |
| 05/29/2008 | US20080125467 (4-methylthiazol-2-yl)methyl 9-hydroxy-8-isobutyl-14-isopropyl-11,18-dimethyl-2,6,12,15-tetraoxo-3,7,13,16-tetraazanonadecan-5-ylcarbamate; Alzheimer's disease |
| 05/29/2008 | US20080125466 Useful in the treatment of conditions associated with pathological receptor activation; inhibiting binding of vanilloid ligand to a capsaicin receptor; (4-tert-Butyl-phenyl)-[1,1-dioxo-6-(3-trifluoromethyl-pyridin-2-yl)-1H-1?6-benzo[d]isothiazol-3-yl]-amine |
| 05/29/2008 | US20080125436 MgluR5 modulators |
| 05/29/2008 | US20080125432 E.g., 2-(4-fluoro-phenylamino)-4-methyl-thiazole-5-carboxylic acid ((S)-1-naphthalen-2-yl-ethyl)-amide; blockingion channels of the Ky1, the Ky3, and the Ky1.5 subfamilies; nervous system disorders; cardiotonic agents; antiepileptic agents; anxiolytic agents; multiple sclerosis; Alzheimer's diseasse |
| 05/29/2008 | US20080125419 Benzothiazole derivatives with activity as adenosine receptor ligands |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125416 Sigma Receptor Inhibitors |
| 05/29/2008 | US20080124572 A carbazole skeleton to which a diarylamino group bonds via a bonding group as a hole transporting material or a hole injecting material has an enhanced efficiency of light emission and is highly practical; enhances yield in device, improves lifetime |
| 05/29/2008 | CA2670404A1 Heteromonocyclic compound and use thereof |
| 05/29/2008 | CA2668567A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods |
| 05/28/2008 | EP1925614A1 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/28/2008 | EP1924579A2 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 05/28/2008 | EP1924568A1 Quinazoline derivatives useful in cancer treatment |
| 05/28/2008 | EP1924561A2 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 05/28/2008 | EP1924560A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 05/28/2008 | EP1846381B1 HETEROARYLACETAMIDES AS FACTOR Xa INHIBITORS |
| 05/28/2008 | EP1633355B1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor |
| 05/28/2008 | EP1605946B1 Thiazoles useful as inhibitors of protein kinases |
| 05/28/2008 | EP1218360B1 Triazine kinase inhibitors |
| 05/28/2008 | CN101189231A Novel cyclic aminophenylalkanoic acid derivative |
| 05/28/2008 | CN101189230A Heterocyclic antiviral compounds |
| 05/28/2008 | CN101189228A Bicyclic [3.1.0] heteroaryl amides as type I glycine transport inhibitors |
| 05/28/2008 | CN101189225A Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity |
| 05/28/2008 | CN101189214A Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides |
| 05/28/2008 | CN100390235C Azo compound and process of producing the same, amd novel compound and process of producing azo compounds using the same |
| 05/28/2008 | CN100390170C 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active |
| 05/28/2008 | CN100390156C Novel antibacterial compounds, process for their preparation and pharmaceutical compositions containing them |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378524 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors. |
| 05/27/2008 | US7378437 Use for the diabetes treatment of compounds or salts thereof, having the following general formula (I): A-(B)b0-(C)c0-NO2 wherein A contains the radical of a drug having an antiiflammatory or analgesic activity, B is a bivalen: linking |
| 05/27/2008 | US7378433 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378421 Chromenone derivatives |
| 05/27/2008 | US7378412 Pharmaceutical compounds |
| 05/27/2008 | US7378397 Peptide derivatives; thyrotropin-releasing hormone-degrading; brain and spinal injuries, central nervous system disorders |
| 05/27/2008 | US7378375 Substituted pyridine herbicides |
| 05/27/2008 | US7378240 hybridization probe; sequence-recognizing nucleic acid portion and a cyanine dye reporter portion; allows real time monitoring of PCR |
| 05/27/2008 | CA2272063C Antithrombotic organic nitrates |
| 05/22/2008 | WO2008061236A2 Sulfoximines as kinase inhibitors |
| 05/22/2008 | WO2008061029A1 Aryl sulfonamide derivatives and methods of their use |
| 05/22/2008 | WO2008060626A2 Compounds for modulating trpv3 function |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059854A1 Piperidine derivatives or salts thereof |
| 05/22/2008 | WO2008059214A1 Bisamlde derivatives and use thereof as fatty acid synthase inhibitors |
| 05/22/2008 | WO2008058341A1 Inhibitors of kinase activity |
| 05/22/2008 | WO2008032191A3 Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
| 05/22/2008 | WO2008021926A3 Modulators of glucocorticoid receptor, and/or ap-1, and/or nf-kb activity and use thereof |
| 05/22/2008 | WO2008021331A3 Oxazolidone derivatives as pr modulators |
| 05/22/2008 | WO2008011392A3 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 05/22/2008 | WO2008000421A3 Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors |
| 05/22/2008 | WO2007138431A3 Azabicyclic ether histamine-3 antagonists |
| 05/22/2008 | WO2007104557A3 Novel heterocyclic nf-kb inhibitors |
| 05/22/2008 | US20080119531 PPAR gamma agonists or partial agonists; type II diabetes, including hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity; compounds have a thiazolidinedione or an oxazolidinedione substituent |
| 05/22/2008 | US20080119529 An epothilone derivative such as epothilone A,B,C or D with a bisphosphonate such as zoledronic acid, a platinum compound such as carboplatin or a vasculostatic compound such as vatalanib succinate; antitumor agents |
| 05/22/2008 | US20080119526 Ep2 receptor agonists |
| 05/22/2008 | US20080119524 Treating conditions related to Ras or Ras-like protein prenylation such as cancer, restenosis, psoriasis, endometriosis, atherosclerosis, ischemia, myocardial ischemic disorders; amide-functional pyrazole compounds containing 2,2-dimethylcyclobutan-1,3-ylene moiety |
| 05/22/2008 | US20080119520 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile |
| 05/22/2008 | US20080119488 Modulators Of Nuclear Receptors |
| 05/22/2008 | US20080119487 Novel non-imidazole compounds |
| 05/22/2008 | US20080119476 Cetp Inhibitors |
| 05/22/2008 | US20080119470 8-hydroxy-3H-quinazolin-4-(thi)one derivatives; ability to enter CNS, sequester transition metals Cu, Zn and Fe from various amiloid beta entities, reducing their toxicity; neurodegenerative disorders; Alzheimer's, Parkinson's, Cruetzfeldt-Jacob diseases, amyotrophic lateral sclerosis, cataract |
| 05/22/2008 | US20080119466 1-(4-Chloro-3-(trifluoro-methyl)phenyl)-3-(4-imidazo-[4,5-c]pyridin-1-ylphenyl)urea; Raf, a serine-threonine protein kinase inhibitor; Raf/MEK/ERK cascade in proliferation of human cancer cells; anticarcinogenic agent; psoriasis, atherosclerosis, chronic rheumatoid arthritis and diabetes |
| 05/22/2008 | US20080119464 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis |
| 05/22/2008 | US20080119461 N-(4,6-dimethyl-2-pyridinyl)-L-valyl-(4R) N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((6-methoxy-1-isoquinolinyl)oxy)-L-prolinamide; viricide; synergistic with other active ingredients |
| 05/22/2008 | US20080119456 [2-benzhydryl-4-(4-chlorophenyl)-thiazol-5-yl]-acetic acid; Chemoattractant Receptor-homologous molecule expressed on T Helper cells type 2 ligand; antiallergen and antiinflammatory agent; asthma, rhinitis, allergic airway syndrome, allergic rhinobronchitis; Alzheimer's disease, rheumatoid arthritis |
| 05/22/2008 | US20080119455 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 05/22/2008 | US20080119454 Aryl carbonyl derivatives as therapeutic agents |
| 05/22/2008 | US20080119419 Bifunctional heterocyclic compounds and methods of making and using same |